ArticleChinese medicine2026
CHRNA3⁺ nociceptors prime the cutaneous sensory interface to enhance electroacupuncture analgesia.
Article in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundRecent evidence determined that acupoints frequently overlap with regions of referred somatic hypersensitivity induced by visceral disease, a phenomenon known as acupoint sensitization. This state is typically characterized by sensory hypersensitivity and functional enhancement, often accompanied by superior therapeutic outcomes following acupuncture. However, the neurobiological mechanisms that prime acupoints for enhanced responsiveness remain poorly understood.
methodsUsing a rat model of TNBS intracolonic injection-induced colitis and relative acupoint sensitization, we investigated the role of CHRNA3⁺ mechanoinsensitive nociceptors (MINs), a subclass of silent C-fiber neurons, in modulating the acupoint sensory interface and electroacupuncture (EA) responsiveness. Behavior tests, neuroanatomical tracing, in situ hybridization, pharmacological blockade, and chemogenetic silencing were employed to assess the involvement of CHRNA3⁺ MINs in the onset of acupoint sensitization. Colonic distension-evoked visceral motor reflex and spinal local field potential recording were utilized to evaluate the contribution of CHRNA3⁺ MINs in the acupuncture-induced analgesic effect.
resultsWe found that CHRNA3⁺ MINs are primarily C nociceptors co-expressing TrkA, pERK, and PIEZO2, innervating both the colon and lumbar skin (BL25 acupoint region) via axonal bifurcation. Colitis significantly activated CHRNA3⁺ nociceptors via the NGF-TrkA/pERK/PIEZO2 pathway, converting them from mechanoinsensitive to mechanosensitive. This activation correlated with increased plasma extravasation and mechanical allodynia at BL25. Pharmacological inhibition of CHRNA3⁺ MINs via pERK blockade or chemogenetic silencing alleviated mechanical hypersensitivity of BL25 and attenuated the analgesic effect of EA on both visceral pain and spinal sensitization.
conclusionOur findings reveal that CHRNA3⁺ silent nociceptors dynamically prime and reshape the sensory interface of the colitis-induced sensitized acupoint BL25, subsequently facilitating both pathological hypersensitivity and therapeutic responsiveness by heightening mechano-responsiveness of the acupoint. This study establishes a mechanistic link between visceral dysfunction, acupoint functional plasticity, and EA-induced therapeutic neuromodulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.